Julia C J P Hagenaars1, Peter C Wever2, André S van Petersen3, Peter J Lestrade4, Monique G L de Jager-Leclercq5, Mirjam H A Hermans6, Frans L Moll7, Olivier H J Koning8, Nicole H M Renders2. 1. Dept. of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. Electronic address: j.c.j.p.hagenaars@gmail.com. 2. Dept. of Medical Microbiology and Infection Control, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. 3. Dept. of Surgery, Bernhoven Hospital, Uden, The Netherlands. 4. Dept. of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. 5. Dept. of Internal Medicine, Bernhoven Hospital, Uden, The Netherlands. 6. Molecular Diagnostics, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. 7. Dept. of Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands. 8. Dept. of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Abstract
OBJECTIVES: The aim of this study was to estimate the seroprevalence of Q fever and prevalence of chronic Q fever in patients with abdominal aortic and/or iliac disease after the Q fever outbreak of 2007-2010 in the Netherlands. METHODS: In November 2009, an ongoing screening program for Q fever was initiated. Patients with abdominal aortic and/or iliac disease were screened for presence of IgM and IgG antibodies to phase I and II antigens of Coxiella burnetii using immunofluorescence assay and presence of C. burnetii DNA in sera and/or vascular wall tissue using polymerase chain reaction (PCR). RESULTS: A total of 770 patients with abdominal aortic and/or iliac disease were screened. Antibodies against C. burnetii were detected in 130 patients (16.9%), of which 40 (30.8%) patients showed a serological profile of chronic Q fever. Three patients presented with acute Q fever, one of which developed to chronic Q fever over time. The number of aneurysm-related acute complications in patients with chronic Q fever was significantly higher compared to patients negative for Q fever (p = 0.013); 9.0% (30/333) vs. 30.0% (6/20). Eight out of 46 patients with past resolved Q fever (8/46, 17.4%) presented with aneurysm-related acute complications (no significant difference). CONCLUSION: The prevalence of chronic Q fever in C. burnetii seropositive patients with abdominal aortic and/or iliac disease living in an epidemic area in the Netherlands is remarkably high (30.8%). Patients with an aneurysm and chronic Q fever present more often with an aneurysm-related acute complication compared to patients without evidence of Q fever infection.
OBJECTIVES: The aim of this study was to estimate the seroprevalence of Q fever and prevalence of chronic Q fever in patients with abdominal aortic and/or iliac disease after the Q fever outbreak of 2007-2010 in the Netherlands. METHODS: In November 2009, an ongoing screening program for Q fever was initiated. Patients with abdominal aortic and/or iliac disease were screened for presence of IgM and IgG antibodies to phase I and II antigens of Coxiella burnetii using immunofluorescence assay and presence of C. burnetii DNA in sera and/or vascular wall tissue using polymerase chain reaction (PCR). RESULTS: A total of 770 patients with abdominal aortic and/or iliac disease were screened. Antibodies against C. burnetii were detected in 130 patients (16.9%), of which 40 (30.8%) patients showed a serological profile of chronic Q fever. Three patients presented with acute Q fever, one of which developed to chronic Q fever over time. The number of aneurysm-related acute complications in patients with chronic Q fever was significantly higher compared to patients negative for Q fever (p = 0.013); 9.0% (30/333) vs. 30.0% (6/20). Eight out of 46 patients with past resolved Q fever (8/46, 17.4%) presented with aneurysm-related acute complications (no significant difference). CONCLUSION: The prevalence of chronic Q fever in C. burnetii seropositive patients with abdominal aortic and/or iliac disease living in an epidemic area in the Netherlands is remarkably high (30.8%). Patients with an aneurysm and chronic Q fever present more often with an aneurysm-related acute complication compared to patients without evidence of Q fever infection.
Authors: Julia C J P Hagenaars; Olivier H J Koning; Ronald F F van den Haak; Bart A N Verhoeven; Nicole H M Renders; Mirjam H A Hermans; Peter C Wever; Robert Jan van Suylen Journal: Int J Exp Pathol Date: 2014-06-23 Impact factor: 1.925
Authors: Jeroen L A Pennings; Marjolein N T Kremers; Hennie M Hodemaekers; Julia C J P Hagenaars; Olivier H J Koning; Nicole H M Renders; Mirjam H A Hermans; Arja de Klerk; Daan W Notermans; Peter C Wever; Riny Janssen Journal: Clin Vaccine Immunol Date: 2015-04-29
Authors: Anne F M Jansen; Annemieke Dinkla; Hendrik-Jan Roest; Chantal P Bleeker-Rovers; Teske Schoffelen; Leo A B Joosten; Peter C Wever; Marcel van Deuren; Ad P Koets Journal: Infect Immun Date: 2018-09-21 Impact factor: 3.441
Authors: J C J P Hagenaars; P C Wever; S O A Shamelian; A S Van Petersen; M Hilbink; N H M Renders; G L De Jager-Leclercq; F L Moll; O H J Koning Journal: Epidemiol Infect Date: 2015-01-22 Impact factor: 4.434
Authors: Marit M A de Lange; Arko Scheepmaker; Wim van der Hoek; Monique Leclercq; Peter M Schneeberger Journal: PLoS One Date: 2019-08-22 Impact factor: 3.240
Authors: Pieter T de Boer; Marit M A de Lange; Cornelia C H Wielders; Frederika Dijkstra; Sonja E van Roeden; Chantal P Bleeker-Rovers; Jan Jelrik Oosterheert; Peter M Schneeberger; Wim van der Hoek Journal: Emerg Infect Dis Date: 2020-02 Impact factor: 6.883
Authors: Daphne F M Reukers; Cornelia H M van Jaarsveld; Reinier P Akkermans; Stephan P Keijmel; Gabriella Morroy; Adriana S G van Dam; Peter C Wever; Cornelia C H Wielders; Koos van der Velden; Joris A F van Loenhout; Jeannine L A Hautvast Journal: PLoS One Date: 2022-02-02 Impact factor: 3.240